These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10849438)
1. Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. Hehner SP; Hofmann TG; Dienz O; Droge W; Schmitz ML J Biol Chem; 2000 Jun; 275(24):18160-71. PubMed ID: 10849438 [TBL] [Abstract][Full Text] [Related]
2. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. Salojin KV; Zhang J; Delovitch TL J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase C theta cooperates with Vav1 to induce JNK activity in T-cells. Möller A; Dienz O; Hehner SP; Dröge W; Schmitz ML J Biol Chem; 2001 Jun; 276(23):20022-8. PubMed ID: 11274147 [TBL] [Abstract][Full Text] [Related]
4. Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway. Charvet C; Auberger P; Tartare-Deckert S; Bernard A; Deckert M J Biol Chem; 2002 May; 277(18):15376-84. PubMed ID: 11859076 [TBL] [Abstract][Full Text] [Related]
5. Protein-tyrosine kinase Pyk2 is involved in interleukin-2 production by Jurkat T cells via its tyrosine 402. Katagiri T; Takahashi T; Sasaki T; Nakamura S; Hattori S J Biol Chem; 2000 Jun; 275(26):19645-52. PubMed ID: 10867021 [TBL] [Abstract][Full Text] [Related]
6. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. Cao Y; Janssen EM; Duncan AW; Altman A; Billadeau DD; Abraham RT EMBO J; 2002 Sep; 21(18):4809-19. PubMed ID: 12234921 [TBL] [Abstract][Full Text] [Related]
7. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation. Faris M; Kokot N; Lee L; Nel AE J Biol Chem; 1996 Nov; 271(44):27366-73. PubMed ID: 8910314 [TBL] [Abstract][Full Text] [Related]
8. Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells. Hehner SP; Li-Weber M; Giaisi M; Dröge W; Krammer PH; Schmitz ML J Immunol; 2000 Apr; 164(7):3829-36. PubMed ID: 10725744 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673 [TBL] [Abstract][Full Text] [Related]
10. Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription. Hofmann TG; Hehner SP; Dröge W; Schmitz ML Oncogene; 2000 Feb; 19(9):1153-63. PubMed ID: 10713703 [TBL] [Abstract][Full Text] [Related]
11. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter. Kaminuma O; Deckert M; Elly C; Liu YC; Altman A Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617 [TBL] [Abstract][Full Text] [Related]
12. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Marinari B; Costanzo A; Viola A; Michel F; Mangino G; Acuto O; Levrero M; Piccolella E; Tuosto L Eur J Immunol; 2002 Feb; 32(2):447-56. PubMed ID: 11813163 [TBL] [Abstract][Full Text] [Related]
13. A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation. Villalba M; Coudronniere N; Deckert M; Teixeiro E; Mas P; Altman A Immunity; 2000 Feb; 12(2):151-60. PubMed ID: 10714681 [TBL] [Abstract][Full Text] [Related]
14. Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte. Tartare-Deckert S; Monthouel MN; Charvet C; Foucault I; Van Obberghen E; Bernard A; Altman A; Deckert M J Biol Chem; 2001 Jun; 276(24):20849-57. PubMed ID: 11262396 [TBL] [Abstract][Full Text] [Related]
15. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820 [TBL] [Abstract][Full Text] [Related]
16. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation. Kuhne MR; Ku G; Weiss A J Biol Chem; 2000 Jan; 275(3):2185-90. PubMed ID: 10636924 [TBL] [Abstract][Full Text] [Related]
17. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells. Tao L; Wadsworth S; Mercer J; Mueller C; Lynn K; Siekierka J; August A Biochem J; 2002 Apr; 363(Pt 1):175-82. PubMed ID: 11903060 [TBL] [Abstract][Full Text] [Related]
18. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. Zhang J; Salojin KV; Gao JX; Cameron MJ; Bergerot I; Delovitch TL J Immunol; 1999 Apr; 162(7):3819-29. PubMed ID: 10201899 [TBL] [Abstract][Full Text] [Related]
19. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade. Kempiak SJ; Hiura TS; Nel AE J Immunol; 1999 Mar; 162(6):3176-87. PubMed ID: 10092768 [TBL] [Abstract][Full Text] [Related]
20. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]